Trademark: 90381374
Word
BEVAZAME
Status
Dead
Status Code
606
Status Date
Monday, June 20, 2022
Serial Number
90381374
Mark Type
4000
Filing Date
Monday, December 14, 2020
Published for Opposition
Tuesday, September 21, 2021
Abandoned Date
Monday, June 20, 2022

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Trademark Events
Jun 21, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 20, 2022
Abandonment - No Use Statement Filed
Nov 16, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 21, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 21, 2021
Published For Opposition
Sep 1, 2021
Notification Of Notice Of Publication E-Mailed
Aug 16, 2021
Approved For Pub - Principal Register
Aug 13, 2021
Teas/Email Correspondence Entered
Aug 13, 2021
Correspondence Received In Law Office
Aug 13, 2021
Teas Response To Office Action Received
Apr 28, 2021
Notification Of Non-Final Action E-Mailed
Apr 28, 2021
Non-Final Action E-Mailed
Apr 28, 2021
Non-Final Action Written
Apr 21, 2021
Assigned To Examiner
Feb 22, 2021
New Application Office Supplied Data Entered In Tram
Dec 17, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24